Despite widespread mass rollout programs, the rapid spread of the SARS-CoV-2 Omicron
variant called into question the effectiveness of the existing vaccines against infection …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine …

There is growing concern that Coronavirus Disease 2019 (COVID-19) vaccine fatigue will be
a major obstacle in maintaining immunity in the general population. In this study, we …

Background Regular, detailed reporting on population health by underlying cause of death
is fundamental for public health decision making. Cause-specific estimates of mortality and …

Vaccination is the primary defense against severe acute respiratory syndrome coronavirus
2, especially among older adults and those with chronic conditions. Using a nationally …

Abstract The SARS-CoV-2 Omicron is currently the predominant circulating variant in the
COVID-19 pandemic. The dominating Omicron sublineages respond to host immune …

Background Detailed, comprehensive, and timely reporting on population health by
underlying causes of disability and premature death is crucial to understanding and …

Background Understanding the health consequences associated with exposure to risk
factors is necessary to inform public health policy and practice. To systematically quantify the …

Targeted public health interventions for an emerging epidemic are essential for preventing
pandemics. During 2020-2022, China invested significant efforts in strict zero-COVID …

Background The COVID-19 pandemic highlighted the fragmented nature of governmental
policy decisions in Europe. However, the extent to which COVID-19 vaccination policies …